NCT03430193 (FIRM) is a NA clinical trial of FIRM in Hip Fractures, sponsored by Seoul National University Bundang Hospital.

Who is sponsoring NCT03430193?

NCT03430193 is sponsored by Seoul National University Bundang Hospital.

What drugs are being tested in NCT03430193?

Interventions in NCT03430193: FIRM, Conventional rehabilitation.

What condition does NCT03430193 study?

NCT03430193 studies Hip Fractures.

Is NCT03430193 still recruiting?

NCT03430193 is currently status unknown. Last updated 15 January 2021.

Last reviewed 2021-01-15 · How we verify

NCT03430193: FIRM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fragility Fracture Integrated Rehabilitation Management (FIRM)

Status unknown NA Last updated 15 January 2021

What this trial tests

NA trial testing FIRM in Hip Fractures in 288 participants. Status unknown.

Timeline

12 February 2018

Primary endpoint
30 September 2021

30 September 2021

Quick facts

Lead sponsor	Seoul National University Bundang Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	288
Start date	12 February 2018
Primary completion	30 September 2021
Estimated completion	30 September 2021
Sites	1 location across South Korea

Drugs / interventions tested

FIRM
Conventional rehabilitation

Conditions studied

Hip Fractures — all drugs for Hip Fractures →

Sponsor

Seoul National University Bundang Hospital

Who can join

65 and older, any sex, with Hip Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A number of studies for clinical pathway (CP) after hip fracture have been suggested to improve post-fracture outcome. However, CP is not carried out properly in most countries due to inadequate system and awareness, and lack of interdisciplinary approach among orthopaedists, geriatricians and rehabilitation specialists. Thus, we developed Fragility fracture integrated rehabilitation management (FIRM), a new standardized guideline and the multidisciplinary fragility fracture care based on the clinical rehabilitation pathway and conducted a prospective study to evaluate the effects of FIRM compared to conventional rehabilitation.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

Multidisciplinary rehabilitation for older people with hip fractures.
Handoll HH, Cameron ID, Mak JC, Panagoda CE, et al · · 2021 · cited 91× · PMID 34766330 · DOI 10.1002/14651858.cd007125.pub3
Comparative effectiveness of fragility fracture integrated rehabilitation management for elderly individuals after hip fracture surgery: A study protocol for a multicenter randomized controlled trial.
Lee SY, Beom J, Kim BR, Lim SK, et al · · 2018 · cited 12× · PMID 29768364 · DOI 10.1097/md.0000000000010763
Functional Outcomes of Fragility Fracture Integrated Rehabilitation Management in Sarcopenic Patients after Hip Fracture Surgery and Predictors of Independent Ambulation.
Lim SK, Beom J, Lee SY, Lim JY. · · 2019 · cited 10× · PMID 31781735 · DOI 10.1007/s12603-019-1289-4
Effects of fragility fracture integrated rehabilitation management on mobility, activity of daily living and cognitive functioning in elderly with hip fracture.
Aftab A, Awan WA, Habibullah S, Lim JY. · · 2020 · cited 9× · PMID 32704272 · DOI 10.12669/pjms.36.5.2412
Effectiveness of a Home-Based Fragility Fracture Integrated Rehabilitation Management (FIRM) Program in Patients Surgically Treated for Hip Fractures.
Choi JH, Kim BR, Nam KW, Lee SY, et al · · 2020 · cited 7× · PMID 33374755 · DOI 10.3390/jcm10010018
Nutritional status modifies the effect of rehabilitation strategy on functional recovery after hip fracture in older adults.
Lim SK, Lim JY. · · 2026 · PMID 42250394 · DOI 10.1016/j.maturitas.2026.109008

Verify or expand the search:

Other recruiting trials for Hip Fractures

Currently open trials in the same condition.

NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
NCT07002723 — Effects of Esketamine Combined With Dexmedetomidine on Postoperative Sleep Quality · NA · recruiting
NCT06893406 — Cervical Myelopathy in Hip Fracture Patients · NA · recruiting
NCT06565910 — Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG) · Phase 4 · recruiting
NCT06455813 — What Laxative Should be Used After Hip Fracture Surgery? · Phase 4 · recruiting

Other Seoul National University Bundang Hospital trials

Trials by the same sponsor.

NCT07459725 — Comparison of EEG-Timed vs. Repetitive Robot Therapy for Chronic Stroke · NA · not yet recruiting
NCT07455279 — Surface Electromyographic Analysis of Normal Swallowing in Children: An Exploratory Study · not yet recruiting
NCT07477574 — Muscle-Specific Multimodal AI for Sarcopenia Diagnosis · NA · not yet recruiting
NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
NCT07305662 — Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGU · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03430193 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Bundang Hospital
Last refreshed: 15 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03430193.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing